AzTrials
AzTrials

ObesityNCT03049696

Does Participation in a Pre-Operative Physical Activity Program Improve Patient Outcomes and Quality of Life?

A study testing ENCOURAGEING START in people with Obesity and Bariatric Surgery, run by University of Manitoba at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of the study is to determine whether participation in a pre-bariatric surgery physical activity and behavior modification/education program (ENCOURAGEING START) that is tailored to the unique needs of obese bariatric surgery patients, improves physical fitness, surgical outcomes, patient health… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
ENCOURAGEING START
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteCanada
Study dates
1 Oct 2017to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female obese adults (Body Mass Index equal to or greater than 35 and under 55);
  • over 18 years old,
  • approved for publicly funded Roux-en-Y gastric bypass surgery by the Centre for Metabolic and Bariatric Surgery,
  • able to attend the regular training and education sessions of the intervention program.

Who cannot join

  • Exclusion criteria include any orthopedic, neurologic or cardiopulmonary conditions that preclude moderately strenuous exercise,
  • Body Mass Index over 55 (super-obese),
  • sleeve gastrectomy, and
  • the inability to commit to attending the regular training and education sessions of the intervention program.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Centre for Metabolic and Bariatric Surgery (CMBS)

    Winnipeg, Manitoba, R3T 2EB

Other trials in Canada

About this study

Official title: An Integrated Surgical and Physical Activity Program to Identify Bariatric Surgery Quality Indicators and Evaluate Patient Outcomes and Quality of Life

The primary objective of the study is to determine whether participation in a pre-bariatric surgery physical activity and behavior modification/education program (ENCOURAGEING START) that is tailored to the unique needs of obese bariatric surgery patients, improves physical fitness, surgical outcomes, patient health and quality of life. Short- (one year) and long- (five year) term outcomes will be compared to matched historical controls (1:1) based on age, gender, and body mass index (BMI) from the existing Manitoba Centre for Metabolic and Bariatric Surgery (CMBS) database. Our findings will determine whether a pre-bariatric surgery physical activity and behavior modification/education program results in improve surgical and patient outcomes and inform the development of evidence-based physical activity (PA) guidelines for bariatric surgery patients and improved CMBS program delivery.

Read the detailed description

The objective of this study is to design and implement a 16-week pre-operative physical activity and behaviour modification/education program (ENCOURAGEING Start) based on a collaborative partnership among the Centre for Metabolic and Bariatric Surgery (CMBS), the University of Manitoba Faculty of Kinesiology and Recreation Management, and Victoria General Hospital (VGH). Twenty-four CMBS patients, approved for bariatric surgery, will participate in the 16 week ENCOURAGEING START program. The goal is to develop evidence-based pre-operative physical activity (PA) guidelines and tools to improve bariatric surgery program delivery and patient outcomes. All patients will receive the Centre for Metabolic and Bariatric Surgery (CMBS) standard of care including two to four multidisciplinary visits over six months, exercise counseling from a kinesiologist, completion of a behavior modification program (Craving ChangeTM), and achievement of lifestyle and dietary modification goals in order to be scheduled for surgery. An interdisciplinary team of nurses, psychologists, dietitians, kinesiologists, anesthetists and internal medicine professionals participate in patient preparation. Intervention group participants will also complete the 16-week supervised physical activity and behaviour modification/education program (ENCOURAGEING START) at no cost. The first eight weeks of the ENCOURAGEING START program is a structured exercise and education period that patients must attend. During the second eight week period, opportunities for drop-in physical activity will be provided or patients can opt for at home exercise. Patient participation in physical activity will be monitored and follow-up with their experiences will be completed (by phone/email). A successfully developed and tested evidence-based physical activity promotion model (designed by co-applicant Dr. Todd Duhamel) has been tailored to the unique needs of the bariatric surgery patient population. It has been been shown successful at increasing weekly physical activity levels in patients with Body Mass Indexes (BMIs) between 30 to 35 and targets the physical and psycho-social-cognitive aspects of health. The intervention will be delivered by a kinesiologist (Certified Exercise Physiologist). Intervention group participants will complete two sessions of supervised, structured exercise classes per week for eight weeks. Progression to a moderate/high-intensity interval program based the patient's capabilities will occur. This approach has been shown to be safe and effective in the bariatric patient population. Participants will also attend education sessions on risk factor reduction, healthy eating, physical activity/exercise, stress management and promotion of self-managed care. Principles of shared decision-making will be utilized so providers and patients involved in the intervention will have shared control of treatment decisions. During the second eight week interval of the 16-week intervention, participants will be provided with access to facilitate attendance at drop-in exercise classes at the Active Living Centre (University of Manitoba). Participants will have the opportunity to meet with the kinesiologist on at least four occasions (60 minutes per meeting) throughout the 16-week intervention. This will provide participants with additional physical activity counseling if they would like more support to overcome the barriers that have prevented them from being physically active in the past. This counseling (and referral aspect) of the model builds upon the earlier experiences in the program and recognizes the importance of support from colleagues, friends and family. Participant attendance during the 16-week intervention will be monitored. In order to ensure adequate participation rates for this study, participant follow-up will be completed by telephone or email (based on participant consent and preference). All patients complete a liquid diet (900 calories per day) for two weeks prior to their surgery in order to reduce intra-abdominal obesity and facilitate the procedure. The study will follow the intension to treat (ITT) model and patient exclusion/withdrawal will be documented and reported according to the CONSORT guidelines. A time series quasi-experimental design will be used to document changes in outcome measures. Short (one year) and long-term (five year) outcomes will be compared to matched historical controls 1:1 based on age, gender, BMI from the existing CMBS database with the goal to determine whether participation in the program improves physical fitness, surgical outcomes, patient health and quality of life for obese patients. The primary outcome of the study is the change in the 6-minute walk test (6MWT) that measures the distance a patient walks in six minutes, unassisted and at a self-selected pace; a validated measure of physical fitness and a well-established measure of functional capacity that is easily tested and in expensive to administer. The 6MWT has been used to measure improvements in functional capacity in pre- and post-bariatric surgery studies. The secondary outcomes include anthropometric measurements (height and weight, BMI (kg/m2), neck circumference, waist and hip circumference, and body composition (Bioelectric Impedance Analysis; BIA), strength measurements (sit to stand and half-squat tests to assess dynamic balance, flexibility and muscular endurance, and the hand grip and arm curl tests to assess upper limb muscle strength and dynamic muscular endurance of the biceps), physical activity level (Actigraph accelerometer), cardiovascular disease risk measurement (blood pressure, total, LDL, and HDL cholesterol and triacylglyceride measurements, blood glucose, HA1c, small and large artery elasticity), frailty measurement, patient quality of life/satisfaction/mental health and depression surveys (Laval Health Related Quality of Life Questionnaire, PHQ9 and HAM-D; see included surveys), Self-compassion, anxiety and physical activity questionnaires, and CMBS program outcome measures (surgical complication rate, hospital length of stay, comorbidity resolution, continued participation in physical activity, weight loss, and weight loss maintenance). Tests at Week 0 (pre-intervention) include the 6MWT, anthropometric, body composition, strength, physical activity level (accelerometer), quality of life/mental health surveys, cardiovascular/ diabetes disease risk measurement, frailty measurement, and arterial elasticity. Tests at week 16 (post-intervention) and 12 months (post-operative) will include 6MWT, anthropometric, strength, physical activity level (accelerometer), quality of life/mental health patient satisfaction surveys, cardiovascular/ diabetes disease risk measurement, frailty measurement, and arterial elasticity. The quality of life/mental health patient satisfaction surveys will be also be completed at the 5 years post-operative period. Two REDCap databases (Data and Survey) will be designed and implemented to facilitate data collection of surgical and patient outcomes, longitudinal survey deployment and patient responses. The surgical outcome metrics are based on the American Society for Metabolic and Bariatric Surgery's (ASMBS) quality indicators for bariatric surgery with the goal to inform and define standardized outcome measures for RYGB surgery in Manitoba and Canada.

Being tested
ENCOURAGEING START
Keywords
Roux-En-Y Gastric Bypass, Bariatric Surgery, Pre-Operative Physical Activity and Education Program, Obesity, Exercise, Behaviour Modification, Surgical Outcomes, Quality of Life
Medical subject headings
Obesity, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ENCOURAGEING STARTBehavioural

    Also called Physical activity and behaviour modification/education program

    16-week physical activity and behaviour modification/education program. CMBS approved bariatric surgery patients participate in structured, supervised physical activity sessions (2 per week) and behaviour modification-education classes during weeks 1 through 8. During weeks 9 through 16, patients will be given access to attend drop in physical activity sessions or can opt to complete physical activity at home.

Study groups in NCT03049696
Study groupRoleWhat they receive
Control Group (Standard of Care)No interventionAll patients will receive the Centre for Metabolic and Bariatric Surgery (CMBS) standard of care including two to four multidisciplinary visits over six months, exercise counseling (kinesiologist), completion of a the CMBS behavior modification program (Craving ChangeTM), and achievement of lifestyle and dietary modification goals in order to be scheduled for surgery. The standard of care will be used as the control group (n=24). Matched historical controls (1:1) will be selected (based on age, gender, and body mass index) from the existing CMBS database.
Intervention Group-ENCOURAGEING STARTExperimentalIntervention group participants (n=24) will receive the standard of care and complete a 16-week supervised physical activity/behaviour modification program at no cost. The first eight weeks of the program involves structured exercise (two per week) and education classes that patients must attend. Progression to a moderate/high-intensity interval program based the patient's capabilities will occur. Participants will also attend education sessions on risk factor reduction, healthy eating, exercise, stress management and promotion of self-managed care. During the second eight week period, participants will be given access to attend drop-in exercise classes or can opt to complete at home exercise. Participants will have an opportunity to meet with the kinesiologist on at least 4 occasions (60 minutes/meeting) for additional physical activity counseling and assistance with overcoming barriers preventing physical activity.
Receives: Behavioral: ENCOURAGEING START

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Six Minute Walk Test (6MWT)

    Measures the distance a patient walks, unassisted and at a self-selected pace, in six minutes. A validated measure of physical fitness and a well-established measure of functional capacity. Has been used to measure improvements in functional capacity in pre- and post- bariatric surgery patients.

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one year.

Secondary outcomes (32)
  1. Anthropometric Measurements-1

    Height (cm)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  2. Anthropometric Measurements-2

    Body Mass Index (kg/m2)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  3. Anthropometric Measurements-3

    Neck circumference (cm)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  4. Anthropometric Measurements-4

    Waist circumference (cm)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  5. Anthropometric Measurements-5

    Hip circumference (cm)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  6. Anthropometric Measurements-6

    Body composition (Bioelectric Impedance Analysis)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, and one year.

  7. Anthropometric Measurements-7

    Weight (kg)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.

  8. Strength Measurements-1

    Half-squat test (to assess dynamic balance, flexibility and muscular endurance).

    Measured: Baseline (0 weeks), 8 weeks,16 weeks, and one year

  9. Strength Measurements-2

    Hand grip test (to assess upper limb muscle strength and dynamic muscle endurance of the biceps).

    Measured: Baseline (0 weeks), 8 weeks,16 weeks, and one year

  10. Strength Measurements-3

    Sit to stand test (to assess dynamic balance, flexibility and muscular endurance).

    Measured: Baseline (0 weeks), 8 weeks,16 weeks, and one year

  11. Strength Measurements-4

    Arm curl tests (to assess upper limb muscle strength and dynamic muscle endurance of the biceps).

    Measured: Baseline (0 weeks), 8 weeks,16 weeks, and one year

  12. Physical Activity Level

    Measured using the Actigraph accelerometer. Each patient will be issued an Actigraph accelerometer that will track their physical activity level.

    Measured: Baseline (0 weeks), 8 and 16 weeks; one year.

  13. Cardiovascular Disease Risk Measurement-1

    Blood pressure (mmHg)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks and one year.

  14. Cardiovascular Disease Risk Measurement-2

    Total cholesterol

    Measured: Baseline (0 weeks), 16 weeks and one year.

  15. Cardiovascular Disease Risk Measurement-3

    LDL cholesterol

    Measured: Baseline (0 weeks), 16 weeks and one year.

  16. Cardiovascular Disease Risk Measurement-4

    HDL cholesterol

    Measured: Baseline (0 weeks), 16 weeks and one year.

  17. Cardiovascular Disease Risk Measurement-5

    Blood triacylglyceride measurement

    Measured: Baseline (0 weeks), 16 weeks and one year.

  18. Cardiovascular Disease Risk Measurement-6

    Blood glucose

    Measured: Baseline (0 weeks), 16 weeks and one year.

  19. Cardiovascular Disease Risk Measurement-7

    Blood glycosylated hemoglobin (HA1c)

    Measured: Baseline (0 weeks), 16 weeks and one year.

  20. Cardiovascular Disease Risk Measurement-8

    Small artery elasticity

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks and one year.

  21. Cardiovascular Disease Risk Measurement-9

    Large artery elasticity.

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks and one year.

  22. Patient quality of life, satisfaction, and mental health-1

    Laval Health Related Quality of Life Questionnaire.

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.

  23. Patient quality of life, satisfaction, and mental health-2

    Patient Satisfaction Questionnaire (PSQ-18)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.

  24. Patient quality of life, satisfaction, and mental health-3

    Patient Health Questionnaire (PHQ-9)

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.

  25. Self-Compassion, Anxiety, and Physical Activity Questionnaires

    Various surveys assembled into one questionnaire package; Self-Compassion Scale, multi-dimensional Health Questionnaire (MHQ)-Health Anxiety Sub-Scale, Affective Responses to a Real Health Problem, Response to Illness Questionnaire, Physical Activity Intentions, Social Physique Anxiety Scale, Body Appreciation Scale-2, Exercise Task Self-Efficacy, and Exercise Regulations Questionnaire (BREQ-3).

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.

  26. Patient quality of life, satisfaction, and mental health-4

    Hospital Anxiety and Depression Scale (HADS),

    Measured: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.

  27. Surgical Outcome Measures-1

    Surgical complication rate.

    Measured: one year

  28. Surgical Outcome Measures-2

    Hospital length of stay.

    Measured: one year

  29. Surgical Outcome Measures-3

    Comorbidity resolution.

    Measured: one year

  30. Surgical Outcome Measures-4

    Continued participation in physical activity.

    Measured: one year

  31. Surgical Outcome Measures-5

    Weight loss (amount; kg).

    Measured: one year

  32. Surgical Outcome Measures-6

    Weight loss maintenance.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2017
  2. Study start1 Oct 2017
  3. Primary completion30 Sep 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Control Group: Publically funded bariatric surgery program administered through the Centre for Bariatric and Metabolic Surgery (CMBS).; Matched control group Intervention Group: CMBS Program standard of care plus the ENCOURAGING START Program (University of Manitoba Active Living Centre)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03049696
Sponsor's protocol ID
H2016:283
Status last verified
Jan 2019
First submitted
18 Jan 2017
Last updated
23 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made available to other researchers.

Questions about this trial

What is this clinical trial studying?

A study testing ENCOURAGEING START in people with Obesity and Bariatric Surgery, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Six Minute Walk Test (6MWT) (time frame: Baseline (0 weeks), 8 weeks, 16 weeks, one year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03049696 | AzTrials